Brief: Sinopharm Group Says HY Net Profit Attributable For China National Medicines Corp Of RMB948.5 Million
Aug 20 (Reuters) - Sinopharm Group Co Ltd 1099.HK: HY NET PROFIT ATTRIBUTABLE FOR CHINA NATIONAL MEDICINES CORP RMB948.5 MILLION HY REVENUE FOR CHINA NATIONAL MEDICINES CORP RMB25.63 BILLION Further company coverage: 1099.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For